Inventor · disambiguated record
Daniel S. Gardner
Also filed as: GARDNER DANIEL S · GARDNER IV DANIEL S
37 granted patents·4 pending applications·296 citations·filing 1999–2021
97Inventor score
Files withBRISTOL MYERS SQUIBB CO28BRISTOL MYERS SQUIBB PHARMA CO5BRISTOL MYERS SQUIBB PHARMA1CHERNEY ROBERT J1DHAR T G MURALI1
Top patents by PatentIndex Score
41 records- 0193US7183270B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 27, 2007·52 cites·19 claims
- 0292US6331541B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 1999·Granted Dec 18, 2001·57 cites·42 claims
- 0391US7601844B2Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 13, 2009·19 cites·8 claims
- 0491US6521592B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Feb 18, 2003·28 cites·16 claims
- 0589US7163937B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jan 16, 2007·29 cites·19 claims
- 0688US10294229B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 21, 2019·9 cites·13 claims
- 0784US7482335B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 27, 2009·6 cites·21 claims
- 0884US7338947B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 4, 2008·6 cites·21 claims
- 0982US7378409B2Substituted cycloalkylamine derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 27, 2008·20 cites·9 claims
- 1081US9657009B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 23, 2017·4 cites·11 claims
- 1181US9169252B2Heteroaryl substituted nicotinamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 27, 2015·5 cites·9 claims
- 1280US9546153B2Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 17, 2017·5 cites·9 claims
- 1380US7985861B2Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jul 26, 2011·3 cites·13 claims
- 1479US6214851B1N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agentDU PONT PHARM CO·Filed 2000·Granted Apr 10, 2001·12 cites·7 claims
- 1578US10202390B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 12, 2019·3 cites·12 claims
- 1678US8642622B2Piperidinyl compound as a modulator of chemokine receptor activityCHERNEY ROBERT J·Filed 2011·Granted Feb 4, 2014·4 cites·8 claims
- 1776US7126010B2Benzylcycloalkyl amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Oct 24, 2006·2 cites·16 claims
- 1874US6608227B1Benzylcycloalkyl amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA·Filed 2000·Granted Aug 19, 2003·7 cites·37 claims
- 1974US6586446B1Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 1, 2003·8 cites·56 claims
- 2073US6864380B2Benzylcycloalkyl amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Mar 8, 2005·5 cites·22 claims
- 2172US6784200B2Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Aug 31, 2004·4 cites·38 claims
- 2271US8501782B2Piperidinyl derivatives as modulators of chemokine receptor activityGARDNER DANIEL S·Filed 2008·Granted Aug 6, 2013·3 cites·11 claims
- 2368US10479793B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 19, 2019·1 cites·3 claims
- 2466US6960666B2Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Nov 1, 2005·2 cites·56 claims
- 2563US7829571B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 9, 2010·0 cites·18 claims
- 2663US7291744B2N-ureidoalkyl-amino compounds as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 6, 2007·2 cites·22 claims
- 2761US2008114052A1Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 2859US7550500B2Bicyclic and tricyclic amines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 23, 2009·0 cites·27 claims
- 2958US10544133B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·0 cites·9 claims
- 3055US9221819B2Spirocyclic compounds as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 29, 2015·0 cites·2 claims
- 3155US6992091B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 31, 2006·0 cites·7 claims
- 3254US10023562B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 17, 2018·0 cites·11 claims
- 3351US2006069128A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityDUNCIA JOHN V·Filed 2005·Application pending·0 cites
- 3450US12492202B2Macrocyclic PAD4 inhibitors useful as immunosuppressantBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 9, 2025·0 cites·21 claims
- 3550US2011245226A1Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 3648US11981680B2Substituted thienopyrroles as PAD4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 14, 2024·0 cites·11 claims
- 3747US8877749B2Spirocyclic compounds as modulators of chemokine receptor activityDHAR T G MURALI·Filed 2010·Granted Nov 4, 2014·0 cites·5 claims
- 3847US8536198B2Piperidine derivatives as modulators of chemokine receptor activitySANTELLA JOSEPH B·Filed 2008·Granted Sep 17, 2013·0 cites·14 claims
- 3946US12473304B2Heterocyclic PAD4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 18, 2025·0 cites·29 claims
- 4043US2022402950A1Substituted benzimidazoles as pad4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 4135US10618903B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Daniel S. Gardner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →